Loading clinical trials...

Setmelanotide in Pediatric Participants With Rare Genetic Diseases of Obesity | Clinical Trials | Clareo Health

COMPLETEDPhase 3NCT04966741

Setmelanotide in Pediatric Participants With Rare Genetic Diseases of Obesity

This is a phase 3 open-label, clinical study to evaluate the efficacy, safety and tolerability of setmelanotide over 1 year of treatment, in pediatric participants aged 2 to \<6 years with obesity due...

Lead sponsor: Rhythm Pharmaceuticals, Inc.•3 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETED

Characterizing the Genotype and Phenotype in Adults With Bardet-Biedl Syndrome

NCT05400278 · Bardet-Biedl Syndrome

UNKNOWNPhase 2

A Phase 2 Study to Assess Efficacy and Safety of LB54640 in Patients With Genetic Obesity

NCT06041841 · POMC Deficiency Obesity, PCSK1 Deficiency Obesity, and more

UNKNOWNNA

Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM)

NCT04874909 · Ciliopathies, Nephronophthisis, and more

COMPLETED

An Observational,Prospective Natural History Study of Early-Onset Extreme Obesity Due to Bi-Allelic Loss-of-Function Mutations in the POMC, PCSK1 or LEPR Genes

NCT03621007 · POMC Deficiency Obesity, PCSK1 Deficiency Obesity, and more

COMPLETED

Bardet-Biedl Syndrome Study: Clinical and Genetic Epidemiology Study in Adults

NCT00213811 · Bardet-Biedl Syndrome, Orphan Diseases

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 27, 2024Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment12

Start dateMar 2022

Last updatedNov 27, 2024

Condition

Bardet-Biedl Syndrome POMC Deficiency Obesity PCSK1 Deficiency Obesity LEPR Deficiency Obesity

Locations shown

Children's Hospital Colorado

Aurora, Colorado

Columbia University Medical Center, Division of Pediatric Endocrinology, Diabetes and Metabolism

New York, New York

Marshfield Clinic Research Foundation

Marshfield, Wisconsin

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 27, 2024Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Setmelanotide in Pediatric Participants With Rare Genetic Diseases of Obesity

What this study is about

Save this trial guide to your notes

Sponsors

Related studies

Characterizing the Genotype and Phenotype in Adults With Bardet-Biedl Syndrome

A Phase 2 Study to Assess Efficacy and Safety of LB54640 in Patients With Genetic Obesity

Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM)

An Observational,Prospective Natural History Study of Early-Onset Extreme Obesity Due to Bi-Allelic Loss-of-Function Mutations in the POMC, PCSK1 or LEPR Genes

Bardet-Biedl Syndrome Study: Clinical and Genetic Epidemiology Study in Adults

Trial snapshot

Condition

Locations shown

For caregivers